This website uses cookies to enhance the user experience.
||
V

VORAX AS821 461 642

Purchase and sale
Limited company
Storgata 1 1440 DRØBAK, Norge
Goods and trade
/ Purchase and sale
/ 46.460 Wholesale of pharmaceutical goods

VORAX AS

Operating
Eie aksjer/andeler i andre selskap, utøve tjenester i forbindelse med investerings- og handelstransaksjoner, ved egen virksomhet eller ved deltagelse i andre selskaper, også i utlandet.

Keywords

pharmaceuticalshospital equipmentorthopedic articles

Organization

CEO
JB

Jarle Bjelland1972

Chairman of the board
JB

Jarle Bjelland1972

Years since formation
8 years
since Sep 26, 2018
Type
Limited company
VAT registered
Yes
Number of employees
0

Ownership

Number of shares and share classes
10,000
1 share class
Total number of shareholders
1
person
Belongs to group of

Financials

Annual total result 2025
444,471
NOK
Total equity 2025
1,530,265
NOK
Last update: Jul 2, 2026

Management

Management / administration

NameRoleShares
JB

Jarle Bjelland

1972

Managing Director/CEO
100 %
directly

Board

NameRoleShares
JB

Jarle Bjelland

1972

Chairman
100 %
directly

Others

NameRoleShares
R
REGNSKAP-FINANS EIDE
Accountant-
P
PEDERSEN & SKOGHOLT AS
Auditor-

Top 10 individual shareholders

NameRoleShares
JB

Jarle Bjelland

1972

Managing Director/CEO, Chairman
100 %
directly
Last update: Oct 9, 2025

Ownership

Company shareholders

NameShare classTotal number of sharesShare
JB

Jarle Bjelland

1972

Ordinary shares
10,000
100 %

Shares owned by the VORAX AS

NameShare classTotal number of sharesShare
O
OPTICELL NORGE AS
Ordinary shares
30,000
100 %
S
SVEVIK AS
Ordinary shares
1,250
50 %
Last update: Jun 2, 2025

Group structure

  • VORAX AS
    Total operating income 2025: NOK 0
    Operating profit 2025: NOK -72,968
    Employees: 0

Financials

in NOK

Summary

Year20252024202320222021
Total operating income
0
0
0
0
0
Annual Total Result
444,471
2,135,482
-1,012,337
-29,873
-12,496
Total assets
8,963,161
8,527,463
116,982
108,409
109,597
Total liabilities
7,432,896
7,441,669
1,166,669
145,760
117,076
Total equity
1,530,265
1,085,794
-1,049,687
-37,351
-7,478

P&L

Year20252024202320222021
Total operating income
0
0
0
0
0
Total operating costs
72,968
10,105
12,338
29,873
12,496
Operating result
-72,968
-10,105
-12,338
-29,873
-12,496
Financial income/costs
517,439
2,145,587
-999,999
0
0
Profit before tax
444,471
2,135,482
-1,012,337
-29,873
-12,496
Total tax & extraordinary income/cost
0
0
0
0
0
Annual Total Result
444,471
2,135,482
-1,012,337
-29,873
-12,496

Balance overview

Year20252024202320222021
Total fixed assets
107,500
5,232,500
107,501
107,500
107,500
Total current assets
8,855,661
3,294,963
9,481
909
2,097
Total assets
8,963,161
8,527,463
116,982
108,409
109,597
Short term debt
7,432,896
7,441,669
1,166,669
145,760
117,076
Long term debt
0
0
0
0
0
Total liabilities
7,432,896
7,441,669
1,166,669
145,760
117,076
Contributed capital
30,000
30,000
30,000
30,000
30,000
Retained earnings
1,500,265
1,055,794
-1,079,687
-67,351
-37,478
Total equity
1,530,265
1,085,794
-1,049,687
-37,351
-7,478
Total equity and liabilities
8,963,161
8,527,463
116,982
108,409
109,597

Classification

21st company classification
BETA
Small company
Category
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
G
Main industrial area
Wholesale and retail trade; repair of motor vehicles and motorcycles
46
Activity
Wholesale trade, except of motor vehicles and motorcycles
46.4
Main industrial group
Wholesale of household goods
46.46
Industrial group
Wholesale of pharmaceutical goods
46.460
Industrial group
Wholesale of pharmaceutical goods